Lifeist Wellness Inc. (LFST.V)
CAD 0.05
(-10.0%)
CAD 0.05
(-10.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 868.65 Thousand CAD | 373.26% |
| 2022 | 183.54 Thousand CAD | -49.59% |
| 2021 | 364.14 Thousand CAD | -32.26% |
| 2020 | 537.56 Thousand CAD | 0.0% |
| 2019 | - CAD | -100.0% |
| 2018 | 25 Thousand CAD | -91.22% |
| 2017 | 284.94 Thousand CAD | 0.0% |
| 2016 | - CAD | 0.0% |
| 2015 | - CAD | 0.0% |
| 2014 | - CAD | 0.0% |
| 2013 | - CAD | 0.0% |
| 2012 | - CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| 2010 | - CAD | 0.0% |
| 2009 | - CAD | 0.0% |
| 2008 | - CAD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 796.83 Thousand CAD | 0.0% |
| 2024 Q1 | 821.1 Thousand CAD | 0.0% |
| 2024 Q3 | - CAD | 0.0% |
| 2023 Q2 | 550.43 Thousand CAD | 280.78% |
| 2023 Q4 | 868.65 Thousand CAD | 74.71% |
| 2023 Q3 | 497.19 Thousand CAD | -9.67% |
| 2023 FY | 868.65 Thousand CAD | 373.26% |
| 2023 Q1 | 144.55 Thousand CAD | -21.24% |
| 2022 Q3 | 223.67 Thousand CAD | -15.64% |
| 2022 FY | 183.54 Thousand CAD | -49.59% |
| 2022 Q1 | 314.46 Thousand CAD | -13.64% |
| 2022 Q4 | 183.54 Thousand CAD | -17.94% |
| 2022 Q2 | 265.13 Thousand CAD | -15.69% |
| 2021 Q1 | 495.82 Thousand CAD | -7.77% |
| 2021 Q3 | 411.13 Thousand CAD | -9.93% |
| 2021 FY | 364.14 Thousand CAD | -32.26% |
| 2021 Q2 | 456.48 Thousand CAD | -7.93% |
| 2021 Q4 | 364.14 Thousand CAD | -11.43% |
| 2020 Q1 | 652.82 Thousand CAD | 0.0% |
| 2020 FY | 537.56 Thousand CAD | 0.0% |
| 2020 Q4 | 537.56 Thousand CAD | -6.94% |
| 2020 Q3 | 577.63 Thousand CAD | -6.25% |
| 2020 Q2 | 616.16 Thousand CAD | -5.62% |
| 2019 Q2 | 12.45 Thousand CAD | -18.61% |
| 2019 Q1 | 15.3 Thousand CAD | -38.82% |
| 2019 Q4 | - CAD | -100.0% |
| 2019 FY | - CAD | -100.0% |
| 2019 Q3 | 10.14 Thousand CAD | -18.5% |
| 2018 Q1 | 216.1 Thousand CAD | 0.0% |
| 2018 Q4 | 25 Thousand CAD | 0.0% |
| 2018 FY | 25 Thousand CAD | -91.22% |
| 2018 Q3 | 25 Thousand CAD | -52.91% |
| 2018 Q2 | 53.1 Thousand CAD | -75.42% |
| 2017 Q3 | 284.94 Thousand CAD | -20.19% |
| 2017 Q1 | 357.01 Thousand CAD | 0.0% |
| 2017 FY | 284.94 Thousand CAD | 0.0% |
| 2017 Q4 | 216.1 Thousand CAD | -24.16% |
| 2017 Q2 | 357.01 Thousand CAD | 0.0% |
| 2016 Q3 | - CAD | 0.0% |
| 2016 Q1 | - CAD | 0.0% |
| 2016 Q4 | 357.01 Thousand CAD | 0.0% |
| 2016 Q2 | - CAD | 0.0% |
| 2016 FY | - CAD | 0.0% |
| 2015 Q2 | - CAD | 0.0% |
| 2015 Q1 | - CAD | 0.0% |
| 2015 FY | - CAD | 0.0% |
| 2015 Q4 | - CAD | 0.0% |
| 2015 Q3 | - CAD | 0.0% |
| 2014 Q4 | - CAD | 0.0% |
| 2014 FY | - CAD | 0.0% |
| 2014 Q3 | - CAD | 0.0% |
| 2014 Q2 | - CAD | 0.0% |
| 2014 Q1 | - CAD | 0.0% |
| 2013 Q2 | - CAD | 0.0% |
| 2013 Q3 | - CAD | 0.0% |
| 2013 Q4 | - CAD | 0.0% |
| 2013 FY | - CAD | 0.0% |
| 2013 Q1 | - CAD | 0.0% |
| 2012 Q4 | - CAD | 0.0% |
| 2012 FY | - CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q1 | - CAD | 0.0% |
| 2012 Q3 | - CAD | 0.0% |
| 2011 Q1 | - CAD | 0.0% |
| 2011 Q4 | - CAD | 0.0% |
| 2011 Q3 | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2010 Q1 | - CAD | -100.0% |
| 2010 Q3 | - CAD | 0.0% |
| 2010 Q4 | - CAD | 0.0% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q2 | - CAD | 0.0% |
| 2009 Q1 | - CAD | 0.0% |
| 2009 Q4 | 120.93 Thousand CAD | 0.0% |
| 2009 FY | - CAD | 0.0% |
| 2008 FY | - CAD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 583.58 Thousand CAD | -48.848% |
| CanadaBis Capital Inc. | 5.91 Million CAD | 85.318% |
| Decibel Cannabis Company Inc. | 32.34 Million CAD | 97.315% |
| Delivra Health Brands Inc. | 1.78 Million CAD | 51.336% |
| Entourage Health Corp. | 5.79 Million CAD | 85.005% |
| Cannara Biotech Inc. | 39.73 Million CAD | 97.814% |
| Medicure Inc. | 229 Thousand CAD | -279.326% |
| PharmaCielo Ltd. | 2.55 Million CAD | 65.981% |
| Rubicon Organics Inc. | - CAD | -Infinity% |
| BioSyent Inc. | 1.03 Million CAD | 16.293% |
| Voyageur Pharmaceuticals Ltd. | 40 Thousand CAD | -2071.643% |